about
Management of people with early or very early stage hepatocellular carcinoma: a network meta-analysisManagement of people with intermediate-stage hepatocellular carcinoma: a network meta-analysisHepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genesSignificance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinomaHepatobiliary Tumors: Update on Diagnosis and ManagementContribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinomaEarly-life exposures to infectious agents and later cancer developmentEmerging role of Toll-like receptor 4 in hepatocellular carcinomaGenetic alterations in hepatocellular carcinoma: An updateNut consumption and risk of cardiovascular disease, total cancer, all-cause and cause-specific mortality: a systematic review and dose-response meta-analysis of prospective studies.The impact of the revolution in hepatitis C treatment on hepatocellular carcinoma.Long-term change in incidence and risk factors of cirrhosis and hepatocellular carcinoma in Crete, Greece: a 25-year study.Frequency and geographic distribution of TERT promoter mutations in primary hepatocellular carcinoma.A potentially functional variant of ARID1B interacts with physical activity in association with risk of hepatocellular carcinoma.Actin-like 6A predicts poor prognosis of hepatocellular carcinoma and promotes metastasis and epithelial-mesenchymal transition.Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.Diabetes and Insulin Therapy, but Not Metformin, Are Related to Hepatocellular Cancer RiskLymphoepithelioma-like hepatocellular carcinoma: Case report and review of the literatureMechanistic Effects of Calcitriol in Cancer BiologyEstablishment of a dual-color fluorescence tracing orthotopic transplantation model of hepatocellular carcinoma.Bioinformatics approach to predict target genes for dysregulated microRNAs in hepatocellular carcinoma: study on a chemically-induced HCC mouse model.The association of six polymorphisms of five genes involved in three steps of nucleotide excision repair pathways with hepatocellular cancer risk.Clinicopathological features and prognostic factors of young patients with surgically treated liver cancerDDR2 facilitates hepatocellular carcinoma invasion and metastasis via activating ERK signaling and stabilizing SNAIL1Time trend analysis of primary liver cancer incidence in Sihui county of Guangdong Province, China (1987-2011).Transarterial oily chemoembolization with lidamycin shows potent therapeutic efficacy in VX2 rabbit liver tumor.Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancerHepatocellular Carcinoma in the Pediatric Population: A Population Based Clinical Outcomes Study Involving 257 Patients from the Surveillance, Epidemiology, and End Result (SEER) Database (1973-2011).GIT1 is a novel prognostic biomarker and facilitates tumor progression via activating ERK/MMP9 signaling in hepatocellular carcinomaMicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice.Bioinformatics analysis of hepatitis C virus genotype 2a-induced human hepatocellular carcinoma in Huh7 cells.Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumoursObesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma.Phenotype and function of CXCR5+CD45RA-CD4+ T cells were altered in HBV-related hepatocellular carcinoma and elevated serum CXCL13 predicted better prognosis.Activating JAK1 mutation may predict the sensitivity of JAK-STAT inhibition in hepatocellular carcinoma.Hepatitis B virus whole-X and X protein play distinct roles in HBV-related hepatocellular carcinoma progressionOptimal 2-[(18)F]fluoro-2-deoxy-D-galactose PET/CT protocol for detection of hepatocellular carcinomaAssociation between Interleukin-18 Polymorphisms and Hepatocellular Carcinoma Occurrence and Clinical ProgressionHepatitis B virus genotypes A and D in Uganda.HBV is a risk factor for poor patient prognosis after curative resection of hepatocellular carcinoma: A retrospective case-control study
P2860
Q24186856-FC6B3D52-7E1A-4ED2-9EF2-AA779297EE63Q24186892-54A6E1A6-29C0-49CC-B8C8-86CC8F846311Q26772317-B735E1AE-32DE-4374-BBB7-DC605E1F67AEQ26773251-97F5EF72-0B04-4339-9548-EEF5CCA824F5Q26775654-9E15084D-6B9A-47C0-96CC-E30625362A56Q26781477-D0C2FEA0-3B6A-4976-9B71-F90DFC8CA060Q26786103-77666F73-F129-4CE7-AD89-55CCDE53AF4EQ26824613-F9DFD2FB-277D-427D-9A53-135B1D6D0C75Q28073241-EC95743C-B5C4-4CF3-91BF-717B660409AAQ30240182-80C8E524-1F56-40DF-B32D-52572B16C123Q30250096-43E7655D-2AA0-44A7-AC15-10A669EEDEFBQ33621731-A3BE10BA-AA63-471E-8381-BC710D7B73B9Q33706203-5AF51675-3FDB-42BB-9D66-013A0F7CF508Q33761625-FD87336A-DB6F-4B30-8BBE-6B819EF4B489Q34506340-52A76881-FA37-42BA-834D-2C882248ED4BQ34681207-B52D03BE-A01E-4DEE-8288-E3FFB13DB91DQ35649664-D4DA3E2C-BAEB-4646-9959-DB13950053F6Q35792987-F2F9E63F-B3AB-48D0-B0B0-DF59526192F2Q35809076-82AD2C80-44DF-41AF-B15E-4A4D9E6F2EBCQ35863746-81A5ABF5-D4B7-453B-91A0-4F8EB94B277DQ35865032-1DC65CCA-92BB-48DE-8806-F7608CD154A9Q35953859-9497B8CE-8BF4-4B5C-AD27-9C14FEBB18F5Q36009055-A0E03DA3-42AB-45B6-A918-946522E6C377Q36053969-F54AB389-6AD0-4582-B8D8-0AA16168283FQ36161857-730233A3-0342-4C9F-AD6B-F1D8380B8C02Q36212684-A2183CED-D09D-4CAC-A853-346828BF32D2Q36273224-89795825-F7F0-4A05-9BC7-846879171238Q36339568-3D2C759F-896E-416B-9A93-44CABFC19011Q36399068-529F38A5-27C4-4C86-B9C0-ECBC6CDDBF37Q36428863-D33BD552-6747-4CCD-8F53-B859F7C3B917Q36462963-1F194943-83C6-48E1-A18E-C9AB84F5BE5DQ36638606-B0246152-5DC8-4FA4-920D-D7356F251E2DQ36652018-B9105E6A-4A01-4193-8719-B8498B1A00ACQ36688945-5E731B65-99A0-4CA7-8B7F-80CF6C335634Q36905691-6EBEE6A0-45D3-4DF2-9705-B1C575B1B38FQ36965734-8356D389-DDA8-42A5-B073-64080200CA53Q37037547-CE539037-62FD-4D7D-891C-A8FCA4D9556EQ37096925-40401BFD-8B12-4D5E-86B8-3B1D6D190291Q37098255-A32EDB99-32BB-44C1-831C-13E3284C172FQ37164927-A1E2964F-1E8E-4CE9-A1AF-F5EFEE08992D
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Hepatocellular carcinoma epidemiology.
@en
type
label
Hepatocellular carcinoma epidemiology.
@en
prefLabel
Hepatocellular carcinoma epidemiology.
@en
P50
P1476
Hepatocellular carcinoma epidemiology.
@en
P2093
Cristina Bosetti
Federica Turati
P304
P356
10.1016/J.BPG.2014.08.007
P577
2014-08-23T00:00:00Z